← Back to Clinical Trials
Recruiting NCT06499935

NCT06499935 The Effect of Taping on Plantar Pressure Distribution in Players With Chronic Ankle Instability

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06499935
Status Recruiting
Phase
Sponsor Cairo University
Condition Ankle Injuries
Study Type INTERVENTIONAL
Enrollment 88 participants
Start Date 2024-05-24
Primary Completion 2024-09-25

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 28 Years
Study Type INTERVENTIONAL
Interventions
Rigid TapingKinesio-TapingSham Taping

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 88 participants in total. It began in 2024-05-24 with a primary completion date of 2024-09-25.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to investigate whether there exists a difference in baropdometric readings of plantar pressure between individuals with chronic ankle instability and normal health individuals, in addition another goal of this study is to investigate the effect of rigid taping vs. kinesio taping on plantar pressure distribution as well as stability markers in individuals with chronic ankle instability. The main questions aimed to answer are: 1. Is there a difference in plantar pressure distribution between individuals with chronic ankle instability and individuals without chronic ankle instability? 2. What effect do rigid and kinesio taping have on plantar pressure distribution and ankle stability markers? 3. Which tape affects plantar pressure distribution and ankle stability better? Participants will: Firstly be divided into two macro groups, one with chronic ankle instability and one without, with an observational part of the study to be carried out to investigate the differences in plantar pressure between both groups. Secondly, the group with chronic ankle instability will be divided into two micro groups one receiving rigid taping and the other receiving kinesio taping, and the immediate effects of these tapes in terms of plantar pressure and ankle stability will be recorded and compared before and after within groups, and after between both groups.

Eligibility Criteria

Inclusion Criteria: * A history of at least 1 significant ankle sprain * The initial sprain must have occurred at least 12 months before study enrollment * A history of the previously injured ankle joint "giving way" and/or recurrent sprain and/or "feelings of instability." * Cumberland Ankle Instability Tool: score of 24 or less Exclusion Criteria: * A history of previous surgeries to the musculoskeletal structures (i.e., bones, joint structures, nerves) in either lower extremity * A history of a fracture in either lower extremity requiring realignment * Acute injury to musculoskeletal structures of other joints of the lower extremity in the previous 3 months that impacted joint integrity and function (i.e., sprains, fracture) resulting in at least 1 interrupted day of desired physical activity.

Frequently Asked Questions

Who can join the NCT06499935 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 28 Years, studying Ankle Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06499935 currently recruiting?

Yes, NCT06499935 is actively recruiting participants. Visit ClinicalTrials.gov or contact Cairo University to inquire about joining.

Where is the NCT06499935 trial being conducted?

This trial is being conducted at Beirut, Lebanon.

Who is sponsoring the NCT06499935 clinical trial?

NCT06499935 is sponsored by Cairo University. The trial plans to enroll 88 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology